Reference7 articles.
1. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: results of a multi-stage, randomised, double-blind, placebo-controlled, phase 3 study;Cudkowicz;Lancet Neurol,2014
2. Berry JD, Shefner JM, Conwit R, et al; Northeast ALS Consortium. Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One 8: e61177.
3. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial;Cudkowicz;Lancet Neurol,2013
4. A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS;Bozik;Amyotroph Lateral Scler Frontotemporal Degener,2014
5. ALS: disease or syndrome?;Van den Berg;J Neurol Neurosurg Psych,2011
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献